OBJECTIVES: This study was undertaken to determine the spectrum and prevalence of mutations in the RYR2-encoded cardiac ryanodine receptor in cases with exertional syncope and normal corrected QT interval (QTc). BACKGROUND: Mutations in RYR2 cause type 1 catecholaminergic polymorphic ventricular tachycardia (CPVT1), a cardiac channelopathy with increased propensity for lethal ventricular dysrhythmias. Most RYR2 mutational analyses target 3 canonical domains encoded by <40% of the translated exons. The extent of CPVT1-associated mutations localizing outside of these domains remains unknown as RYR2 has not been examined comprehensively in most patient cohorts. METHODS: Mutational analysis of all RYR2 exons was performed using polymerase chain reaction, high-performance liquid chromatography, and deoxyribonucleic acid sequencing on 155 unrelated patients (49% females, 96% Caucasian, age at diagnosis 20 +/- 15 years, mean QTc 428 +/- 29 ms), with either clinical diagnosis of CPVT (n = 110) or an initial diagnosis of exercise-induced long QT syndrome but with QTc <480 ms and a subsequent negative long QT syndrome genetic test (n = 45). RESULTS: Sixty-three (34 novel) possible CPVT1-associated mutations, absent in 400 reference alleles, were detected in 73 unrelated patients (47%). Thirteen new mutation-containing exons were identified. Two-thirds of the CPVT1-positive patients had mutations that localized to 1 of 16 exons. CONCLUSIONS: Possible CPVT1 mutations in RYR2 were identified in nearly one-half of this cohort; 45 of the 105 translated exons are now known to host possible mutations. Considering that approximately 65% of CPVT1-positive cases would be discovered by selective analysis of 16 exons, a tiered targeting strategy for CPVT genetic testing should be considered.
OBJECTIVES: This study was undertaken to determine the spectrum and prevalence of mutations in the RYR2-encoded cardiac ryanodine receptor in cases with exertional syncope and normal corrected QT interval (QTc). BACKGROUND: Mutations in RYR2 cause type 1 catecholaminergic polymorphic ventricular tachycardia (CPVT1), a cardiac channelopathy with increased propensity for lethal ventricular dysrhythmias. Most RYR2 mutational analyses target 3 canonical domains encoded by <40% of the translated exons. The extent of CPVT1-associated mutations localizing outside of these domains remains unknown as RYR2 has not been examined comprehensively in most patient cohorts. METHODS: Mutational analysis of all RYR2 exons was performed using polymerase chain reaction, high-performance liquid chromatography, and deoxyribonucleic acid sequencing on 155 unrelated patients (49% females, 96% Caucasian, age at diagnosis 20 +/- 15 years, mean QTc 428 +/- 29 ms), with either clinical diagnosis of CPVT (n = 110) or an initial diagnosis of exercise-induced long QT syndrome but with QTc <480 ms and a subsequent negative long QT syndrome genetic test (n = 45). RESULTS: Sixty-three (34 novel) possible CPVT1-associated mutations, absent in 400 reference alleles, were detected in 73 unrelated patients (47%). Thirteen new mutation-containing exons were identified. Two-thirds of the CPVT1-positive patients had mutations that localized to 1 of 16 exons. CONCLUSIONS: Possible CPVT1 mutations in RYR2 were identified in nearly one-half of this cohort; 45 of the 105 translated exons are now known to host possible mutations. Considering that approximately 65% of CPVT1-positive cases would be discovered by selective analysis of 16 exons, a tiered targeting strategy for CPVT genetic testing should be considered.
Authors: N Tiso; D A Stephan; A Nava; A Bagattin; J M Devaney; F Stanchi; G Larderet; B Brahmbhatt; K Brown; B Bauce; M Muriago; C Basso; G Thiene; G A Danieli; A Rampazzo Journal: Hum Mol Genet Date: 2001-02-01 Impact factor: 6.150
Authors: P J Laitinen; K M Brown; K Piippo; H Swan; J M Devaney; B Brahmbhatt; E A Donarum; M Marino; N Tiso; M Viitasalo; L Toivonen; D A Stephan; K Kontula Journal: Circulation Date: 2001-01-30 Impact factor: 29.690
Authors: David J Tester; Laura J Kopplin; Wendy Creighton; Allen P Burke; Michael J Ackerman Journal: Mayo Clin Proc Date: 2005-05 Impact factor: 7.616
Authors: Alex V Postma; Isabelle Denjoy; Theo M Hoorntje; Jean-Marc Lupoglazoff; Antoine Da Costa; Pascale Sebillon; Marcel M A M Mannens; Arthur A M Wilde; Pascale Guicheney Journal: Circ Res Date: 2002-10-18 Impact factor: 17.367
Authors: David J Tester; Daniel B Spoon; Hector H Valdivia; Jonathan C Makielski; Michael J Ackerman Journal: Mayo Clin Proc Date: 2004-11 Impact factor: 7.616
Authors: Giulia d'Amati; Alessia Bagattin; Barbara Bauce; Alessandra Rampazzo; Camillo Autore; Cristina Basso; Kathy King; Maria Daniela Romeo; Pietro Gallo; Gaetano Thiene; Gian Antonio Danieli; Andrea Nava Journal: Hum Pathol Date: 2005-07 Impact factor: 3.466
Authors: Silvia G Priori; Carlo Napolitano; Mirella Memmi; Barbara Colombi; Fabrizio Drago; Maurizio Gasparini; Luciano DeSimone; Fernando Coltorti; Raffaella Bloise; Roberto Keegan; Fernando E S Cruz Filho; Gabriele Vignati; Abraham Benatar; Angelica DeLogu Journal: Circulation Date: 2002-07-02 Impact factor: 29.690
Authors: Barbara Bauce; Alessandra Rampazzo; Cristina Basso; Alessia Bagattin; Luciano Daliento; Natascia Tiso; Pietro Turrini; Gaetano Thiene; Gian Antonio Danieli; Andrea Nava Journal: J Am Coll Cardiol Date: 2002-07-17 Impact factor: 24.094
Authors: David J Tester; Argelia Medeiros-Domingo; Melissa L Will; Carla M Haglund; Michael J Ackerman Journal: Mayo Clin Proc Date: 2012-06 Impact factor: 7.616
Authors: Christine A Kenyon; Randall Flick; Christopher Moir; Michael J Ackerman; Christina M Pabelick Journal: Paediatr Anaesth Date: 2010-03-22 Impact factor: 2.556
Authors: Andrew P Landstrom; Andrew L Dailey-Schwartz; Jill A Rosenfeld; Yaping Yang; Margaret J McLean; Christina Y Miyake; Santiago O Valdes; Yuxin Fan; Hugh D Allen; Daniel J Penny; Jeffrey J Kim Journal: Circ Arrhythm Electrophysiol Date: 2017-04
Authors: Michael Arad; Michael Glikson; Dalia El-Ani; Lorenzo Monserrat-Inglesias Journal: Ann Noninvasive Electrocardiol Date: 2012-10 Impact factor: 1.468
Authors: Shuying Gao; David J Sandstrom; Harold E Smith; Brigit High; Jon W Marsh; Howard A Nash Journal: Anesthesiology Date: 2013-03 Impact factor: 7.892
Authors: Xiaolu Pan; Leonne Philippen; Satadru K Lahiri; Ciaran Lee; So Hyun Park; Tarah A Word; Na Li; Kelsey E Jarrett; Rajat Gupta; Julia O Reynolds; Jean Lin; Gang Bao; William R Lagor; Xander H T Wehrens Journal: Circ Res Date: 2018-09-28 Impact factor: 17.367